The PGY2 Investigational Drugs and Research pharmacy residency program offers the opportunity to develop clinical, analytical, teaching, and leadership skills required to support clinical trials research. The program encompasses the fields of clinical research, medication safety, leadership, regulatory compliance, and quality assurance and is designed to develop expert skills in pharmacists’ provision of care for patients enrolled in clinical trials. Upon completion the resident will have expertise in clinical trial design and conduct, pharmacy operations and clinical services for the research enterprise, and investigational drug service pharmacy leadership within an interprofessional environment.

• Graduation from an ACPE-accredited PharmD Degree program
• Completion from ASHP-accredited PGY-1 program
• Eligibility for Texas licensure
• Virtual or Formal Interview
• Application deadline Jan. 2, 2026

About University of Texas (UT) Southwestern Medical Center

UT Southwestern Medical Center is a premier academic health system, with a top-ranked medical school and patient care services ranked as one of the best in the Dallas-Ft. Worth Metroplex, providing a full range of patient care. The growing health system contains 900 staffed beds and serves 37,000 inpatients annually. The Department of Pharmacy maintains academic relationships with many Colleges of Pharmacy and the UT Southwestern Medical School, ensuring a strong commitment to the education of pharmacy residents and students.

Connections working at University of Texas (UT) Southwestern Medical Center